Skip to main content
World Today News
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Menu
  • Home
  • News
  • World
  • Sport
  • Entertainment
  • Business
  • Health
  • Technology
Blood Pressure Medication Prevents More Heart Attacks and Strokes Than It Causes Serious Falls, Study Finds

Blood Pressure Medication Prevents More Heart Attacks and Strokes Than It Causes Serious Falls, Study Finds

November 20, 2026 Health Desk Health

Blood pressure-lowering medication prevents significantly more serious cardiovascular events, such as heart attacks and strokes, than it causes in serious falls, according to a study published on Friday in Nature Communications.

The research, which analyzed electronic health records from over 5.5 million patients in England, provides a data-driven framework to help clinicians weigh the clinical benefits of antihypertensive therapy against potential risks like dizziness and renal complications.

Key Clinical Takeaways:

  • For every 1,000 patients treated over a decade, medication prevents approximately eight major cardiovascular events while causing roughly two serious falls.
  • The cardiovascular benefits of treatment consistently outweigh the risk of falls, even among older patients living with frailty.
  • New clinical modeling demonstrates that while heart attack and stroke prevention is clear, trade-offs regarding fainting and acute kidney injury require more nuanced, personalized decision-making.

Predicting Cardiovascular Outcomes with STRATIFY-CVD

Researchers at the Nuffield Department of Primary Care Health Sciences, University of Oxford, developed a cardiovascular risk calculator, known as STRATIFY-CVD, to address limitations in existing models. By integrating routinely collected NHS patient data, the tool estimates the likelihood of serious cardiac events over a five- to 10-year horizon. The model accounts for age, medical history, and existing comorbidities, providing a more precise risk profile than previous standards like QRISK2.

The study, funded by the Wellcome Trust and the National Institute for Health and Care Research, highlights how treatment impact varies by demographic. While the net benefit is positive across the population, the absolute risk reduction changes significantly based on a patient’s specific health status.

Blood Pressure Medication Prevents More Heart Attacks and Strokes Than It Causes Serious Falls, Study Finds
Photo: miragenews.com

Adverse events may outnumber prevented incidents

The research illustrates that the trade-off between efficacy and side effects is not uniform across all adverse events.

While the prevention of heart attacks and strokes remains the primary clinical objective, the data suggests that for outcomes like low blood pressure and elevated potassium levels, the frequency of adverse events may exceed the number of prevented cardiovascular incidents. These secondary effects, however, are generally considered less severe than a stroke or myocardial infarction.

Deciding whether to prescribe blood pressure medication isn’t always straightforward, particularly when someone is older, living with frailty or several other health conditions. Doctors need to consider not just whether a treatment works, but how much an individual patient is likely to benefit and what risks matter most to them. Nuffield Department

This assessment was provided by James Sheppard, a professor from the Nuffield Department of Primary Care Health Sciences at the University of Oxford and senior author of the paper, as reported by Mirage News.

Individualized care plans needed for diverse patients

The findings emphasize the necessity of individualized care plans, particularly for patients who do not fit into standard risk categories. Because the study included patients who had previously experienced cardiovascular events or were already on statin therapy, it offers a broader perspective than many traditional clinical trials.

Whether this model will be integrated into standard electronic health record systems for real-time clinical decision support remains a subject for further implementation research.

As the oldest university in the English-speaking world, with evidence of teaching dating to 1096, the University of Oxford has long shaped clinical research. It operates the world’s oldest university museum, the Ashmolean, and the largest university press, Oxford University Press. The institution comprises 43 colleges and, in the fiscal year ending 31 July 2025, reported a consolidated income of £3.02 billion, including £801.3 million from research grants.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Keep reading

  • Dune: Spice Wars Soundtrack Has 15 Tracks, 55 Minutes per khinsider.com
  • PAHO: México, US, Bolivia Lose Measles-Free Status After 12-Month Spread

Related

Search:

World Today News

World Today News is your trusted source for global journalism — breaking headlines, in-depth analysis, and reporting from around the world.

Quick Links

  • Privacy Policy
  • About Us
  • Accessibility statement
  • California Privacy Notice (CCPA/CPRA)
  • Contact
  • Cookie Policy
  • Disclaimer
  • DMCA Policy
  • Do not sell my info
  • EDITORIAL TEAM
  • Terms & Conditions

Browse by Location

  • GB
  • NZ
  • US

Connect With Us

© 2026 World Today News. All rights reserved. Your trusted global news source directory.
For contact, advertising, copyright, issues email: [email protected]

Privacy Policy Terms of Service